TRAJENTA DUO 2.5/1000 MG 10 TABLETS | Linagliptin Metformin
TRAJENTA DUO 2.5 MG/1000 MG 10 TABLETS contain Linagliptin 2.5 mg and Metformin 1000 mg, a prescription antidiabetic combination used with diet and exercise to improve blood sugar control in type 2 diabetes.
TRAJENTA DUO 2.5 MG/1000 MG 10 TABLETS
TRAJENTA DUO 2.5/1000 MG TABLETS (Linagliptin 2.5 mg + Metformin 1000 mg): Comprehensive Guide and Benefits
Introduction to TRAJENTA DUO 2.5/1000 MG TABLETS
DPP-4 Inhibitor and Biguanide Combination for Type 2 Diabetes Management
TRAJENTA DUO 2.5 MG/1000 MG TABLETS contain Linagliptin 2.5 mg and Metformin Hydrochloride 1000 mg. It is a prescription oral antidiabetic medicine used as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus when treatment with both Linagliptin and Metformin is appropriate.
This combination provides two complementary mechanisms: Metformin improves insulin sensitivity and reduces glucose production by the liver, while Linagliptin enhances glucose-dependent insulin release by inhibiting the DPP-4 enzyme.
Prescription Status: Prescription-only medicine.
Key Benefits of TRAJENTA DUO 2.5/1000 MG TABLETS
Helps improve blood glucose control in adults with type 2 diabetes.
Supports reduction of elevated fasting and post-meal blood sugar levels.
Improves insulin sensitivity through Metformin action.
Enhances the body’s natural insulin response through Linagliptin.
Provides convenient combination therapy in a single tablet.
Composition
Active Ingredients:
Linagliptin – 2.5 mg
Metformin Hydrochloride – 1000 mg
Dosage Form:
Film-coated Oral Tablet
Drug Class:
DPP-4 Inhibitor (Linagliptin)
Biguanide Antidiabetic Agent (Metformin)
Manufacturer/Marketer:
Boehringer Ingelheim India Pvt. Ltd.
How TRAJENTA DUO 2.5/1000 MG Works
TRAJENTA DUO contains two antidiabetic medicines with different actions:
Linagliptin
Inhibits the DPP-4 enzyme.
Increases incretin hormone activity.
Helps stimulate insulin release when blood glucose levels are high.
Helps reduce glucagon secretion, decreasing excess glucose production.
Metformin
Reduces glucose production in the liver.
Improves the body’s response to insulin.
Helps improve glucose utilization by tissues.
Together, these effects help maintain better blood sugar control.
Usage Instructions
Take TRAJENTA DUO 2.5/1000 MG TABLETS exactly as prescribed by your doctor.
Usually taken with meals to reduce stomach-related side effects.
Swallow the tablet whole with water.
Do not crush, chew, or split the tablet unless advised.
Take it at the same time each day.
Do not stop the medicine without medical guidance.
Medicinal Advantages
Type 2 Diabetes Management
Helps maintain improved blood glucose levels.
Supports long-term diabetes management along with lifestyle modifications.
Dual Mechanism Therapy
Combines insulin-sensitizing effects of Metformin with glucose-dependent insulin regulation from Linagliptin.
May help patients who require additional glucose control beyond single-drug therapy.
Convenience of Combination Treatment
Reduces the number of separate tablets required for eligible patients.
Mechanism of Action
Linagliptin blocks DPP-4, preventing the breakdown of incretin hormones such as GLP-1 and GIP. This increases insulin secretion after meals and decreases glucagon release.
Metformin activates pathways that reduce glucose production by the liver and improve insulin sensitivity, helping lower blood glucose levels.
Off-Label Uses
Linagliptin and Metformin combinations may occasionally be evaluated by healthcare professionals for conditions outside approved indications based on individual patient assessment.
Any off-label use should only be undertaken under medical supervision.
Expert Advice
Follow a balanced diet and regular exercise plan along with medication.
Monitor blood glucose levels as advised by your doctor.
Inform your doctor about kidney or liver problems before starting treatment.
Report symptoms of low blood sugar if used with insulin or sulfonylurea medicines.
Maintain regular diabetes follow-up appointments.
Precautions
Kidney Disease
Metformin-containing medicines require assessment of kidney function before and during treatment. Patients with significant kidney impairment may require alternative therapy.
Liver Disease
Inform your doctor about liver problems before starting TRAJENTA DUO.
Alcohol Consumption
Avoid excessive alcohol intake, as it may increase the risk of serious Metformin-related complications.
Pregnancy and Breastfeeding
Consult your healthcare provider before using TRAJENTA DUO during pregnancy or breastfeeding.
Drug Interactions
Inform your doctor if you are taking:
Insulin.
Sulfonylureas.
Other diabetes medicines.
Diuretics.
Corticosteroids.
Medicines affecting kidney function.
Contrast agents used in imaging procedures.
Possible Side Effects
Common side effects may include:
Nausea.
Diarrhea.
Stomach discomfort.
Vomiting.
Headache.
Altered taste.
Low blood sugar (especially when combined with other glucose-lowering medicines).
Seek medical advice for severe abdominal pain, persistent vomiting, allergic reactions, or unusual weakness.
Storage Instructions
Store below 30°C.
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Frequently Asked Questions (FAQs)
Q: What is TRAJENTA DUO 2.5/1000 MG used for?
A: TRAJENTA DUO 2.5/1000 MG is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
Q: What are the ingredients in TRAJENTA DUO 2.5/1000 MG?
A: Each tablet contains Linagliptin 2.5 mg and Metformin Hydrochloride 1000 mg.
Q: Is TRAJENTA DUO insulin?
A: No. TRAJENTA DUO is an oral antidiabetic medicine containing a DPP-4 inhibitor and a biguanide.
Q: Should TRAJENTA DUO be taken with food?
A: Yes, taking it with meals may help reduce gastrointestinal side effects associated with Metformin.
Q: Can TRAJENTA DUO be stopped suddenly?
A: Do not stop this medicine without consulting your doctor, as blood sugar levels may become uncontrolled.
Product Tags
TRAJENTA DUO 2.5/1000 MG 10 TABLETS, Linagliptin 2.5 mg, Metformin 1000 mg, DPP-4 Inhibitor Tablet, Type 2 Diabetes Medicine, Blood Sugar Control Tablet, Oral Antidiabetic Medicine, Diabetes Management Tablet, Boehringer Ingelheim, Prescription Diabetes Medicine.
